Chiropractors in West Lafayette Bra, IN Accepting Medicare
2 Chiropractors found. Showing 1 - 2
 Healers' Heart Integrative Health Care P.c. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3180 Trego Ct, West Lafayette Bra, IN 47906 Phone: 765-497-2266 |
 Dr. Mary Kriebel, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 1231 Cumberland Ave, Suite D, West Lafayette Bra, IN 47906 Phone: 765-463-7337 |
News Archive
SARS-CoV-2 variant of concern could cause further epidemics in UK
The team – from the University of Warwick, the University of Manchester, and the University of Oxford – say that a variant of concern that has either a substantial transmission advantage over resident lineages, or the ability to evade vaccine- or infection-induced immunity, can be expected to drive a wave of infections and hospitalizations similar to that seen in the country during the winter of 2020-21.
New drug test promises to yield quick and effective response for cancer therapy
A group of scientists from Hamburg may have taken a big step towards more effective cancer drug development, Europe's largest cancer congress, ECCO 15 - ESMO 34 [1], heard today (Wednesday 23 September). Dr Ilona Schonn, Director of Cell Culture Research at Indivumed GmbH, told the conference that they had developed a preclinical drug test platform that would enable researchers to analyse tumour tissue for individual patient drug responses on the molecular level.
Nine suggestions to prevent sexual abuse among children
Pediatricians know that when they discuss seat belt, bicycle and water safety during annual wellness visits they are helping to reduce a child's risk of harm. Those same visits should include messages about personal space and privacy, says Dr. Martin A. Finkel, an internationally known expert in the prevention and treatment of child sexual abuse, and he is urging pediatricians to begin a dialogue that will help children avoid the physical and mental health consequences of sexual abuse.
Northwestern Memorial trial may wean kidney transplant patients off antirejection drugs
After a transplant surgery, anti-rejection drugs for the organ recipient are a must, but with prolonged use can have serious side effects, including infections, heart disease and cancer.
Depomed acquires U.S. rights to NUCYNTA franchise from Janssen Pharmaceuticals
Depomed, Inc. today announced that it has closed the acquisition of the U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals, Inc. for $1.05 billion. The NUCYNTA franchise includes: NUCYNTA ER (tapentadol) extended release tablets indicated for the management of pain, including neuropathic pain associated with diabetic peripheral neuropathy (DPN), severe enough to require daily, around-the-clock, long-term opioid treatment; NUCYNTA (tapentadol), an immediate release version of tapentadol, for management of moderate to severe acute pain in adults; and NUCYNTA (tapentadol) oral solution, an approved oral form of tapentadol that has not been launched.
› Verified 9 days ago